Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Chronic, Moderate to Severe Osteoarthritis Knee Pain
NCT02558439 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 175
Last updated 2017-08-08
Summary
The purpose of this study is to evaluate the safety and efficacy of a single injection of CNTX-4975 in subjects with chronic, moderate to severe osteoarthritis knee pain.
Conditions
Interventions
- DRUG
-
CNTX-4975
- OTHER
-
Placebo
Sponsors & Collaborators
-
Centrexion Therapeutics
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 45 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-08-31
- Primary Completion
- 2016-10-31
- Completion
- 2017-02-28
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Intra-articular CX-011 to Treat Moderate to Severe Pain From Knee Osteoarthritis
NCT07308834 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase II Study Looking at Moderate to Severe Osteoarthritis Knee Pain
NCT00394563 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Efficacy Study of Anti-inflammatory (Canakinumab) and Cartilage Stimulating (LNA043) Drugs Injected Into the Knee Joint of Participants With Knee Osteoarthritis (OA)
NCT04814368 ·Status: TERMINATED ·Phase: PHASE2
-
A Safety and Tolerability Study of UBX0101 in Patients With Osteoarthritis of the Knee
NCT03513016 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Safety, Tolerability, Preliminary Efficacy of Intra-articular LNA043 Injections in Patients With Articular Cartilage Lesions and Knee Osteoarthritis.
NCT03275064 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety and Efficacy of Subcutaneously Administered REGN475 in Patients With Osteoarthritis of the Knee
NCT01239017 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Assess the Safety and Efficacy of a Single Dose of UBX0101 in Patients With Osteoarthritis of the Knee
NCT04129944 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Resiniferatoxin for Knee Pain in Moderate to Severe Osteoarthritis
NCT03542838 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects
NCT02536833 ·Status: COMPLETED ·Phase: PHASE2
-
Tanezumab in Osteoarthritis of the Knee
NCT00733902 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Intra-articular DLX105 Applied to Patients With Severely Painful Osteoarthritis of the Knee
NCT00819572 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Safety and Efficacy of 2ccPA in Patients With Symptomatic Knee Osteoarthritis
NCT05807529 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis
NCT02067611 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Controlled Study to Evaluate Efficacy and Safety of Intra-articular Ampion for Osteoarthritis Pain in Knee
NCT02024529 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Study of CG100649 for Primary Osteoarthritis in Male Subjects
NCT00530452 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase 1, Dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SM04690 in Moderate to Severe Knee Osteoarthritis (OA)
NCT02095548 ·Status: COMPLETED ·Phase: PHASE1
-
An Efficacy and Safety Study of Two Doses of Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee
NCT01839331 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare Levels of Capsaicin After Intra-Articular Injection and Topical Application in Patients With Painful Knee Osteoarthritis
NCT03576508 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain
NCT04809376 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis Knee Pain
NCT03081806 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of a Subcutaneous Tanezumab Titration Dosing Regimen in Subjects With Moderate to Severe Osteoarthritis of the Hip or Knee
NCT02697773 ·Status: COMPLETED ·Phase: PHASE3
-
Tanezumab In Osteoarthritis Of The Hip Or Knee
NCT00985621 ·Status: TERMINATED ·Phase: PHASE3
-
A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of KA34 in Subjects With Knee Osteoarthritis
NCT03133676 ·Status: COMPLETED ·Phase: PHASE1
-
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee
NCT00689273 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating the Safety and Efficacy of a Second Course of TPX-100 in Subjects Who Previously Received TPX-100 for Patellar Osteoarthritis Involving Both Knees
NCT02837900 ·Status: COMPLETED ·Phase: PHASE2